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Abbreviations. CeD, Celiac Disease; BODIPY,  boron-dipyrromethene; CD, Circular 
Dichroism; PPII, poly-proline II;  AFM, Atomic Force Microscopy; DLS, Dynamic Light 
Scattering, MD, Molecular Dynamics Simulation. 
 





 Celiac Disease (CeD) is a highly prevalent chronic immune-mediated 
enteropathy developed in genetically predisposed individuals after ingestion of a group of 
wheat proteins (called gliadins and glutenins). The 13mer α-gliadin peptide, p31-43, 
induces proinflammatory responses, observed by in vitro assays and animal models, that 
may contribute to innate immune mechanisms of CeD pathogenesis. Since a cellular 
receptor for p31-43 has not been identified, this raises the question of whether this peptide 
could mediate different biological effects. In this work, we aimed to characterize the p31-43 
secondary structure by different biophysical and in silico techniques. By Dynamic Light 
Scattering (DLS) and using an oligomer/fibril-sensitive fluorescent probe, we showed the 
presence of oligomers of this peptide in solution. Furthermore, Atomic Force Microscopy 
(AFM) analysis showed p31-43 oligomers with different height distribution. Also, peptide 
concentration had a very strong influence on peptide self-organization process. Oligomers 
gradually increased their size at lower concentration. Whereas, at higher ones, oligomers 
increased their complexity, forming branched structures. By Circular Dichroism, we 
observed that p31-43 self-organized in a poly-proline II conformation in equilibrium with β-
sheets-like structures, whose pH remained stable in the range of 3 to 8. In addition, these 
findings were supported by Molecular Dynamics Simulation. The formation of p31-43 
nanostructures with increased β-sheet structure may help to explain the molecular 
etiopathogenesis in the induction of pro-inflammatory effects and subsequent damage at 
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Introduction  
 
Gliadins and glutenins are proteins present in wheat, that form a viscoelastic 
structure, called gluten, through non-covalent interactions and disulphide bond exchange 
in the presence of water [1]. This protein complex has been extensively studied due to its 
technological properties in food manufacture, and because its consumption triggers Celiac 
Disease (CeD) in genetically predisposed individuals [2]. CeD is a highly prevalent chronic 
immune-mediated enteropathy which occurs in 1% of worldwide population, characterized 
by damage to small intestinal mucosa due to an exacerbated immune response by 
overactivation of gluten-specific T lymphocytes [3]. 
 Gliadins are the ethanol-soluble fraction of gluten which can be separated by gel 
electrophoresis at acid pH in α/β-, -, and ω-gliadins [4]. The primary structure of gliadins 
has several repetitive sequences rich in proline and glutamine residues. These proteins 
are resistant to degradation by gastrointestinal enzymes, and consequently, several long 
peptides may remain in the gut lumen [5]. Different mechanisms have been suggested for 
their translocation into the mucosa of the small intestine, where they exhibit immunogenic 
properties through binding to HLA class II molecules becoming T cell epitopes [6, 7]. 
Among wheat proteins, peptides from α-gliadins are the most studied. The peptide 56-87 
from α-gliadin fraction, called 33mer, has been extensively studied as model of T cell 
epitope because it induces an strong adaptive immune response in CeD patients [8], 
whereas the α-gliadin peptide p31-43, induces a non-HLA mediated inflammatory 
response as well as several toxic effects evaluated by ex vivo and in vitro assays [9-12]. 
Using an experimental model developed by our group, the in vivo biological effects of p31-
43 have been recently studied [13, 14]. We observed that wild type mice treated with p31-
43 presented histological alterations and increased number of intraepithelial lymphocytes, 
production of proinflammatory mediators and cell death. We also demonstrated that 
biological effects depend on the activation of the NLRP3 inflammasome [14]. In the other 
hand, Villella et.al [15] showed that p31-43 is capable of inhibiting the cystic fibrosis 
transmembrane conductance regulator (CFTR) and reduces ATPase activity of the 
nucleotide‐binding domain‐1 (NBD1) impairing its function. This generates epithelial 
stress, tissue transglutaminase and inflammasome activation, NF‐κB nuclear translocation 
and IL‐15 production. Considering that the activation of the inflammasome platform has 
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signals [16, 17], we hypothesize that p31-43 self-assembling properties may be critical to 
its biological effects. 
Though, biological effects triggered by p31-43 (LGQQQPFPPQQPY) are observed 
very rapid upon treatment, the surface cell receptor or the mechanism of peptide entry 
have not been identified [18]. In our previous study, we showed by Circular Dichroism (CD) 
and Transmission Electron Microscopy (TEM) that p31-43 presents a poly-proline II (PPII) 
structure and forms oligomers which may promote the activation of the inflammasome 
platform [14]. To gain structural details on p31-43, several spectroscopic and microscopic 
techniques were used, as well as, coarse-grained dynamic simulation in order to 
understand at a molecular level, peptide interactions and driven forces that leads to p31-




Characterization of p31-43 oligomers by Spectroscopic and Atomic Force Microscopy 
techniques.  
 
In a previous report, we showed by TEM that p31-43 self-aggregates presenting a 
PPII structure, in agreement with CD determinations [14]. Subsequent NMR experiments 
performed by Calvanese L. et al. [19] confirmed that this peptide is able to adopt this 
structure. 
To further evaluate the self-assembly propensity of p31-43 and the characteristics 
of the oligomers [14], we decided to use a variety of biophysical tools. Firstly, we used a 
fluorescent probe containing a boron dipyrromethane scaffold (BODIPY) [20]. The 
molecule used in this work is able to sense the presence of particular hydrophobic patches 
that can be generated by the presence of oligomeric structures. This probe was used to 
evaluate the self-aggregation of the β-amyloid peptide, detecting oligomers prior to the 
formation of fibrils which could not be detected by other probes [21]. When this probe 
binds to a specific site, an increment of its fluorescence intensity is detected at 
approximately 540 nm when sample is excited at 525 nm. Thus, to analyze if p31-43 can 
self-assemble in solution, we measured fluorescence emission spectra at different peptide 
concentrations (10, 50 and 100µM) in presence of 1µM BODIPY. A concentration-
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concentration, more binding sites were available. These results support the existence of 
p31-43 soluble oligomers in the range from 10 to 100μM (Figure 1A).  
Furthermore, Dynamic Light Scattering (DLS) was used to detect structures in 
solution. In this study, we evaluated p31-43 at 125µM. This concentration was chosen 
because samples at lower concentrations lack of detectable dispersion. The solution 
presented high polydispersity, suggesting the presence of different oligomer populations in 
the sample. Two main populations were observed, one of 107±7.5nm of hydrodynamic 
diameter and big aggregates with an average diameter of 493±31nm (Figure 1B). These 
findings prompted us to propose that, at this concentration, p31-43 oligomers are in 
equilibrium with larger nanostructures. 
In our previous study, by using Circular Dichroism (CD) and Transmission Electron 
Microscopy (TEM), we demonstrated that p31-43 presents a PPII structure and forms 
oligomers which may promote the activation of the inflammasome platform [14]. Herein, 
we explored the self-assembly process of p31-43 by Atomic Force Microscopy as 
complementary technique, which allows a deeper evaluation of the morphology of the 
oligomers because of its higher resolution achieved in a hydrated environment. This tool 
provides a topographic image of the sample [22], providing a visualization of p31-43 self-
assembly with minimum interference [23-25]. This methodology was previously used to 
understand the self-association process of different proteins and peptides such as β-
amyloid [26] and 33-mer gliadin peptide [27] and protein such as α-synuclein [28], the silk 
protein [29], elastomeric ones as resilin [30] and it has been widely used to characterize 
protein complexes, oligomers and fibers [31]. In this case, 5, 50 and 100µM p31-43 
solutions were prepared to cover the same range of concentrations used in previous in 
vivo assays (6,5 y 65µM). The samples were freshly prepared to avoid a time-dependence 
effect [32].  
At 5µM final concentration, p31-43 self-assembled as isolated spherical oligomers 
randomly distributed on the mica surface with different heights (Figure 2A). When a height 
distribution and statistical analysis of the whole sample deposited in mica was performed, 
we found that most of the structures were of 2.6±2.08nm height average (Figure 3A), with 
a minor proportion of oligomers having higher values. The high standard deviation 
indicated the presence of different oligomers, as it was detected by cross section analysis 
of the aggregates (indicated with white arrows in Figure 2A and 2B). Oligomers presented 
different heights that were divided into three groups: 1.2; 2.25 and 3.25nm, suggesting that 












This article is protected by copyright. All rights reserved 
was analyzed, we observed diverse oligomer populations (Figure 2C and 2D), indicating 
that different species are in equilibrium. Most oligomeric structures presented a mean 
height of 5±3nm (Figure 3B). In this case, we observed three kinds of round shaped 
species with a height around 2.4, 4 and 10nm. Interestingly, higher structures of 20-60nm 
were detected. This suggests that some precipitation of soluble species may have been 
occurred. Finally, we analyzed a 100µM solution were clusters of small height, as well as, 
amorphous aggregates with approximately lengths of 250nm were observed (Figure 2E), 
having widths of 100-140nm and heights of 5nm (Figure 2F). Considering that the height 
of these aggregates was in the range of the oligomers observed in the 50µM sample, we 
propose that they were produced by lateral association of oligomers.  
Gliadin p31-43 peptide presents a poly-proline II conformation in equilibrium with 
extended structures. 
We aimed to evaluate whether the structure of p31-43 was affected by different 
physiological pHs that resemble the ones of the gastrointestinal tract. This is a relevant 
issue because despite the absence of ionizable side chains in the p31-43 sequence, the 
C-terminal carboxylates are generally expected to be protonated at pH values near 3.3. To 
this end, we assessed the secondary structure by CD in 20mM phosphate buffer at pHs: 
3.0, 5.0, 7.4, 8.0 at 50µM final peptide concentration in MilliQ water (Figure 4). In our 
previous work, we demonstrated that p31-43 presents a PPII structure at 4ºC [14] which 
was also observed for other gliadin peptides such as the 33-mer gliadin peptide [33]. As 
this conformation is always in equilibrium with other structures and it has been shown that 
PPII is more populated at low temperatures [34-36] we selected 4°C as the one to study 
pH dependence on the peptide conformation. Herein, we confirm that p31-43 presents a 
PPII structure which remains stable at different pHs. 
Aimed to get further details on the self-organization process of p31-43, we 
reanalyzed the conformations of the oligomers obtained performing coarse-grained (CG) 
simulations [14]. As shown in Figure 5A, p31-43 peptides undergo spontaneous 
oligomerization in aqueous solution, as evidenced by a decrease in the radius of gyration 
from 10nm i.e., half the maximum distance between peptides in the initial configuration of 
the simulation to 3.1nm that corresponds to the final radius of the 50-mer. Once a compact 
state is reached, the N- and C-terminal moieties remain close to each other forming intra 
and intermolecular salt bridges that optimize electrostatic interactions among different 
peptides (inset in Figure 5A). The formation of salt bridges contributes to decrease the 
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for the former oligomer shows a clear shift to lower pH than expected for a single 
carboxylate in solution (Figure 5B), explaining the absence of pH dependence observed in 
the CD experiments.  
Next, we studied the peptide structure in a wider range of concentrations from 10 to 
500µM. We observed a characteristic PPII structure signal [34] determined by a negative 
band near 203nm and a positive band at 225nm, at 4°C throughout all concentrations 
(Figure 6A). Interestingly, when the p31-43 peptide concentration is increased, a 
hypochromic displacement of the negative band occurs, that is characteristic of a self-
assembly process. In line with this, the secondary structure content calculated along 
dynamic simulations suggested that the aggregation process induced a small increase in 
PPII conformation in two central Prolines, as well as, in -sheet conformation spread along 
the non-Proline amino acids (Figure 6C and 6D). A secondary structure analysis per 
aminoacid of the monomeric and oligomeric states, identified a structured segment located 
in the central portion of the peptide, which could account for the phenomenon observed in 
CD experiment. As the simulation progressed and the oligomer was formed, an increment 
of 28% of the PPII conformation was observed in residues Pro8 and Pro9, while more 
external aminoacids experienced an increase in the  extended conformation stabilized by 
the formation of -sheets among other peptides in the oligomer. 
To study the effect of temperature over p31-43 structure, we performed CD 
experiments at four different temperatures increasing from 4°C to 37°C (Figure 6B). We 
observed that the negative band had a hypochromic behavior with a displacement from 
203nm to 205nm and the positive band at 225nm reduced its signal. These features along 
with the presence of an isodichroic point at 210nm, indicate that the PPII structure is in 
equilibrium with extended structures such as β-turns and β-sheet, due to the close 
proximity of the dihedral angles in the conformational landscape [34-35]. To confirm this 
behavior, we used the BestSel server [37] which analyses CD spectra and gives an overall 
idea of the percentage of each structure in the whole peptide population at different 
conditions. The analysis of the 4°C spectra by this server indicated that around 60% of the 
signal corresponded to structures as PPII, 18% are turns and 22% are anti-β strand. The 
same analysis for the 37°C spectra, showed that the PPII-like structures decreased to a 
56% and the anti-β strand increase up to 26%. Moreover, as CD spectra could be 
considered the result of a combination of different structures, the mathematical spectrum 
subtraction of a protein at different conditions is an adequate tool to evaluate 
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between 37°C and 4°C and observed a negative band at 220nm and a positive one at 
200nm, indicating that at physiological temperature, the p31-43 peptide has an increase of 
the β-sheet like conformation (Figure 6E). At lower temperatures, the peptide had a PPII 
structure, whereas at 37 °C there was an increment of the β-sheet like one component. 
However, the PPII structure remained as the most representative.  
The PPII conformation is stable in the presence of chaotropic agents such as urea and 
guanidinium chloride [39]. To evaluate whether these agents were able to modify the p31-
43 structure, 50µM and 200µM p31-43 solutions were dissolved in presence of 8M urea. 
At both concentrations, a positive band was observed at 225nm that confirms the PPII 
structure of p31-43 (Figure 6C). 
On the other hand, to confirm that the species were in conformational equilibrium, a 
200µM p31-43 solution was incubated in the presence of trifluorethanol (TFE) (Figure 6D). 
This co-solvent is used to favor intramolecular bonds, such as the ones present in α-helix 
and β-sheets [40]. A hypochromic displacement of the negative band from -11000 to -6000 
was observed when TFE concentration was increased from 0% to 50% together with a 
small red shift from 203nm to 205nm. Interestingly, the positive band at 225nm decreased 
when TFE was added, also an isodichroic point a 210nm was observed, suggesting that 
species may alternate between PPII conformation and extended structure. At TFE 50%, 
the positive band at 195nm and the red shift at 208nm suggested that p31-43 was in 
equilibrium with β-sheet like structures. Also, when the spectra of TFE 0% and 50% were 
analyzed using BestSel server, we detected a decrease of PPII-like structures from 60% to 
50%, and an increase of the anti-parallel β-structure from 23% to 29%. This result was 
also confirmed by the mathematical subtraction of CD spectra between 50% and 0% TFE, 
which showed a characteristic β-sheet like structure (Figure 6F). Though, these findings 
suggest that p31-43 has mainly a PPII structure in equilibrium with β-sheet like structures, 
which depends on its self-assembly and the polarity of the environment. 
 
Self-assembly process of p31-43 depends on peptide concentration. 
 
Protein oligomerization and aggregation is a highly time and temperature dependent 
process, among other factors. Therefore, we run a series of assays to study p31-43 self-
assembling in a period of 7 days. For that, p31-43 solutions were incubated at 4 ºC, to 
diminish the ongoing aggregation reaction and preserve the first stages of the peptide self-
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morphological change of p31-43 oligomerization by AFM. A similar methodology was 
previously performed to evaluate the self-assembly process of proteins as the serum 
amyloid A1.1 [42], fibrils from the bacterial protein MinE [43] and the hen egg lysozyme 
[44]. We evaluated two peptide concentrations, 10µM and 50µM. At concentrations higher 
than 100µM, a full coverage of the surface was observed; therefore, it was not possible to 
evaluate the system by AFM.  
 
Analysis of a freshly prepared 10µM sample deposited on mica surface showed three 
populations of oligomers. The smaller ones had an average height of 2.61±0.54 nm, 
composed by 3-4 monomers, the intermediate ones of 4.71±0.86 nm height with 5-6 
monomers per oligomer and higher ones of 6.259±0.71nm height composed by 8-10 
monomers. The higher and the smaller ones were in minor proportion as shown in Figures 
7A and 8A. It is worth to mention that the oligomers detected at 10μM were bigger than 
the ones observed at 5μM, thus confirming that the self-organization process depends on 
peptide concentration. 
Next, the sample was incubated for 4 days at 4°C and deposited on the mica surface. 
At this condition, peptide oligomers self-associated generating larger isolated clusters with 
an average height of 5.56±0.96nm. These values indicate that the initial oligomers 
observed in Figure 7A, associated to form plane-cluster like structures (Figure 7B and 
Figure 8B). These wider planar cluster (with approximately 32 monomers) may be 
generated by self-association of the smaller ones presented in Figure 8C. This finding 
allowed us hypothesizes a colloidal behavior of p31-43 peptide. 
Spherical oligomers were detected after a continuous incubation of 7 days. However, 
there were no planar-cluster assemblies (Figure 7C). These spherical oligomers are 
higher than the planar clusters and had an average height of 22.2±8.2nm. This indicates 
that the oligomers observed in Figure 7B might be produced by rearrangement of wider 
structures, producing higher stable spherical structures which have less surface exposure, 
as it was previously observed in other systems [45, 46]. 
When the self-organization process was analyzed in 50µM peptide solutions, the 
structures observed differed from the ones detected at 10µM, confirming that this process 
is dependent on peptide concentration. In the freshly prepared sample, small and higher 
spherical oligomers were detected (Figure 9A and 10A). The smaller oligomeric 
structures average height was 4.1±1.6nm (approximately 6-8 monomers per oligomer) 
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structures had heights of 50nm, similar to Figure 2. These could have been produced by 
some precipitation that might occur during the deposition. This was observed in all three 
samples prepared at different times.  
After a 4 day-incubation of the sample at 4°C the spherical oligomers arranged as a 
chain-like fractal network. Interestingly, in this structure, little individual oligomers were 
detected, since most of the peptide is forming these new linear structures. The smaller 
oligomers had an average of 8.07±4.13nm and the bigger ones were approximately 
21.47±5.47nm height (12-20 monomers per oligomer). For this structure, the fractal 
dimension (Df ) which described the self-similarity of the system was calculated. Using the 
box counting method as it is described in the SI, we obtained a Df of 1.4 (Figure 9B). This 
characteristic self-organization ability of p31-43 was also observed for the silicatenin 
protein [47] and the 33-mer gliadin peptide [27, 48]. 
After incubating the sample at 4°C for 7 days, the linear chain network described 
above, continued evolving forming longer linear structures like fractals with an average 
height of 14.53±6.71nm. Interestingly, no individual oligomers were distinguished in this 
structure, suggesting that they may have interacted with each other to form the small linear 
structures detected. However, some large clusters with a height of 40.33±6.5nm could be 
observed, which might have been generated by some precipitation (Figure 9C). When Df  
was calculated, a value of 1.7 was obtained, suggesting that, at this time, the structures 
were formed by a diffusion limited aggregation (DLA) mechanism. By this theory, the 
peptide is described as a colloidal particle in which every particle collision leads to an 
irreversible association and formation of a fractal structure, which has a typical Df  value of 
1.7-1.8 [29, 47, 49].  
 
Discussion 
Celiac disease (CeD) is a common gastrointestinal disease triggered by dietary 
gluten peptides. Though, the specific immune response against a group of immunogenic 
peptides is well established, the role of gliadin peptides in the induction of inflammatory 
responses is less understood [12, 13]. The p31-43 gliadin peptide, generated by digestion 
of gastrointestinal and brush border enzymes, is the most used model peptide to evaluate 
the innate immune response in CeD [9]. Using an experimental model in mice, we have 
shown that p31-43 induces local inflammatory responses and increased cell death in small 
intestine, which requires MyD88 and type I IFN pathways [13]. Further in vivo assays 
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capacity to sense signals derived from cell damage produced by nanostructures or by 
direct interaction with these species [16, 17, 50]. By CD and TEM, we showed that p31-43 
is able to form oligomers in the multinanometer scale [14]. Since a cell surface receptor for 
p31-43 has not been identified [18], we hypothesize that structural features of p31-43 may 
be of key importance in the induction of different biological effects.  
Fluorescence spectroscopy and DLS allowed assessing whether the self-
organization process occurs in solution. A fluorescent probe called BODIPY, which was 
previously employed to detect oligomers of β42 amyloid peptide was used [21]. The 
fluorescence signal of this probe in presence of p31-43 suggests that oligomers with 
hydrophobic patches are presented in solution. The oligomer size increased at higher 
peptide concentrations as it was detected in the spectra. In addition, DLS measurements 
confirmed that higher ordered and stable structures were present in solution (Figure 1). 
This result is in concordance with our CD studies performed at a wide range of 
concentrations which showed a self-assembly behavior (Figure 6A). This process was 
also previously described in elastomeric proteins such as lamprim [51], elastin II fragments 
[38, 52] and the 33-mer gliadin peptide [27,33,48].  
The AFM analysis confirmed that p31-43 oligomerizes and the size of the oligomers 
and the structures observed are dependent on peptide concentration. Results obtained at 
5µM and 50μM, showed spherical nanostructures with different heights that were in 
equilibrium with each other. However, at 50μM some bigger oligomers and precipitation 
was detected. We hypothesize that, at these concentrations, p31-43 behaves as a colloid 
nanostructure where each spherical oligomer tends to interact with each other as it was 
observed in terminal fragments of serum amyloid A [42]. At 100µM, the peptide generates 
clusters and amorphous aggregates in solution that may be deposited on the mica. These 
structures have an average height similar to the oligomers at 50μM (Figure 2), suggesting 
that p31-43 self-assembles to generate these structures. This behavior was also observed 
for the β-amyloid peptide [53] which is typical for colloidal structures at high concentration 
[49]. It is worth to mention that these structures are in concordance with our previous 
observations by TEM confirming that p31-43 self-assembles into oligomers and clusters. 
CD analysis showed that p31-43 presented PPII secondary structure, which was 
also recently confirmed by NMR experiments [19]. Since this conformation lacks of 
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appropriate characteristics to be in equilibrium with other conformations. In fact, evaluation 
of the peptide at 200µM solution at different temperatures, showed a conformational 
transition from PPII to β-sheet like structures as it was inferred by both the use of BestSel 
and difference spectra, and supported by molecular simulations. The treatment of 200µM 
and 50µM solutions with urea returns p31-43 to a PPII conformation while TFE, a co-
solvent that favors hydrogen bonds, produced 50% of a β-sheet like signal (Figures 6B, C 
and D). These observations strongly suggest that the peptide is in equilibrium with 
extended and folded structures at physiological temperatures. Similar behavior was 
observed in other proteins and peptides such as the amyloidogenic exon-30 of tropoelastin 
[35]. The same self-association propensity was confirmed at the molecular level by the 
coarse-grained molecular dynamics simulations of a monomer in a box containing 50 
replicas. 
When the p31-43 was studied at different pHs by CD and MD, no structural 
transitions were observed, indicating that its structure it is not affected by changes in pH in 
the range of 3 to 8. Analysis of the oligomeric state obtained by simulations indicated that 
the formation of salt bridges between terminal zwitterionic moieties is determinant for pH 
stability, shifting C-terminal values to acidic conditions in almost one pKa unit. These 
findings suggest that the aggregation process might contribute to the resistance of 
properties of p31-43 would not be affected by changes in pH along the gastrointestinal 
tract and in the small intestinal mucosa.  
To get further insight into the self-assembly behavior of p31-43, we performed an AFM 
evaluation, assessment already used to understand protein aggregation, as it was done for 
the polyalanine expansion of PHOX2B aggregation [55]. We observed that p31-43 self-
assembly process showed different behavior depending on the peptide concentration as 
described for the β-amyloid peptide [56] and the N‐terminal serum amyloid A peptides [57]. 
We hypothesize that the peptide behaves as a colloidal nanoparticle that could self-
associate depending on its concentration. At the lower concentration, the small colloidal 
particles, following a self-association process, produce planar clusters that then reorganize 
into spherical bigger oligomers. Since small oligomers co-exist with bigger ones and bigger 
structures are detected over time, we propose that this process is driven by an Ostwald 
ripening like process [58, 59]. 
At 50μM p31-43 self-organize differently, the peptide structure changes from 
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days, this behavior progresses to large branched structures with a fractal morphology and 
a Df ~1.7 suggesting a DLA mechanism. This self-organization behavior was previously 
detected in 33-mer gliadin peptide [27,33,48] and whey proteins [60, 61]. Peptide 
concentration could strongly influence the type of interactions established among 
monomers leading to differences in the self-assembly behavior [49]. Based on these 
findings, a scheme of self-assembly process is proposed (Figure 11).  
The driven forces of the self-organization of p31-43 may be explained by its high 
content of glutamines. In poly-glutamine sequences, the formation of oligomers and higher 
ordered structures is a consequence of the hydrophobic effect and specific hydrogen 
bonds generated among monomers [62]. In the case of p31-43, an uncharged peptide, 
both intermolecular forces might be the key drivers of the self-assembly characteristic [63]. 
However, the formation of oligomers does not preclude that p31-43 may act also as 
monomer. Recent work by Villela et al. [15] showed that monomeric p31-43 binds to the 
NBD1 subunit of the chloride channel (cystic fibrosis transmembrane conductance 
regulator, CFTR) and inhibit its function. As consequence, autophagy is altered, and NFκB 
and inflammasome pathways are activated, producing the release of inflammatory 
mediators.  
Conclusion 
In conclusion, considering that the surface cell receptor or the mechanism of 
peptide entry have not been identified, and recently in silico analysis suggested that p31-
43 does not bind to HLA class II molecules [19], our findings open a new perspective to 
understand the biological effects of this peptide in the induction of inflammatory and cell 
death pathways. As a monomer, it can mediate selective effects as, the recently shown, 
inhibition of the subunit of the chloride channel. Oligomers, in turn, may play a role in the 
multiple and fast non-HLA mediated mechanisms, like altering vesicular trafficking and 
cellular stress [12], and our own work on the activation of NLRP3 inflammasome [14]. 
Altogether, these findings help to understand the innate immune response elicited as 
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Materials and Methods 
 
1. Sample preparation 
The p31-43 peptide was purchased from GeneCust (Luxembourg). The peptide was 
dissolved in Milli Q water generating a mother solution of 600 μM which was stored at -20 
ºC. From this mother solution the working samples were prepared before the 
measurements and stored on ice. Meanwhile experiments were carried out, the samples 
were kept on ice to avoid effects of temperature on the peptide conformation. 
The kinetic assay was performed by preparing peptide dilutions from the stock solution to 
the desired concentration (10 and 50 M) and incubating them at 4 ºC for 0 (fresh 
solution), 4, 7 and 14 days in a cold room, on ice, before deposition on the mica surface. 
 For reproducibility, three different peptide batches were used for the experiments 
presented in this work. The concentration dependent experiments solutions at 10, 50, 200 
and 500µM in MilliQ water were prepared. 
 For the CD experiments in Urea 8M the peptide mother solution was directly dissolved in 
an adequate urea concentration solution to achieve the final urea concentration required. 
The sample was incubated 3 hours to reach the equilibrium. The Trifluorethanol titration 
experiment (TFE) was performed on cuvette and the concentration of the peptide was 
recalculated in each titration step the sample was incubated 10 minutes before data 
acquisition. The kinetic assay was performed by preparing peptide solutions from the 
mother one to the desired concentration and incubating it at 4ºC at 0 (fresh solution), 4, 7 
and 14 days in a cold room and ice before the deposition on the mica surface.  
 
2. Fluorescence Spectroscopy 
The emission spectra of p31-43 in presence of BODIPY probe was performed in a JASCO 
FP 8300. In this case, Milli Q water solution of the peptide at the concentration 10, 50 and 
100μM were freshly prepared and BODIPY probe was added at 1μM final concentration. 
Also, we used water as control. Then, the emission spectrum of each sample was 
obtained by exciting the samples at 525nm wavelength and the slits used were 5nm for the 
excitation and emission.  
 
3. Dynamic Light Scattering  
Samples of p31-43 gliadin peptide were dissolved on water and filtered with a 200nm filter 
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triplicate using a Zetasizer (Nano-ZS) from Malvern Instruments and the analysis of the 
autocorrelation functions obtained was performed by Dispersion Technology Software 
(DTS) from Malvern. 
 
4. Atomic Force Microscopy 
All images to characterize the peptide self-assembly were obtained in Tapping mode AFM 
with MultiMode Scanning Probe Microscope (Nanoscope V; Bruker, Santa Barbara, CA) 
equipped with a Nanoscope V controller (Veeco, Santa Barbara, CA, USA), using probes 
doped with silicon nitride (RTESP, Veeco with tip nominal radius of 8 -12 nm, 271e311 
kHz, force constant 20-80 N m-1). Typical rate scanners were 1 Hz.  
Water aqueous solutions of the peptides at concentrations from 10, 50 and 100µM were 
deposited on freshly cleaved mica, and left to interact with the surface for five minutes at 
room temperature. Then the samples were dried by a Nitrogen flow. The height of the 
observed architectures was determined by cross section using Nanoscope Analysis 1.40 
software (Bruker).  
 
5. Circular Dichroism 
CD spectra of peptide solutions at were recorded on a Jasco J-810 CD spectropolarimeter 
using a Peltier system as temperature controller. For this experiment five scans were 
acquired in the range of 190–250nm at a selected temperature (from 4ºC to 37ºC with an 
incubation of 10 minutes for each measurement). The scanning speed of 50nm per minute 
was used. The spectra were obtained employing a 1-mm and 0.1-mm quartz cuvettes. 
Blank scans were subtracted from the spectra. The data were expressed as the mean 
residue molar ellipticity in deg cm2 dmol-1. Smooth noise reduction was applied eventually 
when it was necessary using a binomial method. Graphics were represented using the 
program Origin (OriginLab). 
 
6. Molecular simulations 
Molecular dynamics simulations were performed at the coarse grained level using the 
SIRAH force field [14, 64] at 37 oC and 1 atm with no added salt to mimic the conditions of 
circular dichroism experiments (see above). Oligomerization was simulated by introducing 
50 replicas of the isolated, zwitterionic, peptide in different conformations randomly 
selected along a MD trajectory of an isolated peptide. The simulation of the oligomer was 
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peptides were placed in random conformations within a computational box leaving at least 
4nm between each replica. Secondary structure and atomistic structures from coarse-
grained conformers were calculated using SirahTools [65]. Secondary structure contents 
per aminoacid were averaged over the last 100ns of the trajectory. pKa values on C-
terminal moieties were calculated with PropKa [66] using the pdb2pqr server [67] on 10 
conformers taken from the last 100ns of simulation.  
7. Fractal Dimension:  
Fractal Dimension is a measure of the complexity of a system. It is a scaling rule that is 
used to compare how pattern details change when the scale varied from minor to major 
resolution. Mathematically, it is expressed as  
𝑁 ∝  𝜖−𝐷𝑓 
Where Df is the fractal dimension, 𝑁 is the number of pieces observed in each new 
resolution and  𝜖 is the scale used for each pieces.  
FracLac software from Image J was employed for the determination of Df using the box 
counting procedure. The basic procedure is to lay systematically a series of grids of 
decreasing calibre (the boxes) over an image and record data (the counting) for each 
successive calibre. The program gives access to Df obtained by the application of several 
mathematical algorithms. 
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Figure 1. Characterization of p31-43 oligomers in solution by BODIPY fluorescence 
and Dynamic Light Scattering. A) Fluorescence emission spectra of p31-43 in presence 
of BODIPY at 1µM final concentration in presence of different peptide concentration 
solutions: () 10, () 50 and () 100µM peptide final solution. The buffer plus the probe 
was used as control (). The excitation wavelength was 525 nm and the slits used were 
5nm for the excitation and emission. Triplicates were performed for each condition B) 
Hydrodynamic diameter distribution of p31-43 obtained by Dynamic Light Scattering at 
125µM concentration prepared in MilliQ water. The sample was previously centrifuged and 
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Figure 2. Morphological characterization of p31-43 oligomers 
Gliadin p31-43 solutions at different concentrations in Milli Q water were deposited on 
mica surface and AFM images were obtained in tapping mode. A) 5μM p31-43 solution (3 
x 3μm2). B) Cross-section of the oligomers indicated in A. C) 50μM p31-43 solution (10 x 
10μm2). A zoom in the top left corner of the image shows different oligomeric species. D) 
Cross-section of the oligomers indicated in C: E) AFM image of 100µM peptide solution (5 
x 5μm2). F) Cross-section of the structures indicated in E. Color reference for cross-section 
images: (a) blue: higher oligomers, (b) red: intermediate oligomers and (c) green: smaller 

















Figure 3. Height distribution of the structures observed by AFM. Analysis of the 
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Figure 4. Circular Dichroism of p 31-43 in phosphate buffer at different pHs. Analysis 
at pH 3.0 (■), pH 5.0 (●), pH 7.4 (▲) and pH 8.0 (▼) A) at 4°C and B) at 37°C. The 
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Figure 5. Coarse-grained Molecular Dynamics simulations of p31-43. A) The radius of 
gyration of 50 monomers of the peptide along the simulation. The marked decrease 
suggests that oligomerization happens spontaneously in absence of significant energetic 
barriers. In the final configuration (lower inset) the termini of the peptides form salt bridges 
that optimize electrostatics interactions (bottom inset). B) Normalized counts of pKa values 
assigned by PropKa of the carboxylate moieties of p31-43. Comparison between the 
average secondary structure of: C) an isolated monomer and D) the oligomer formed by 
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averaged during the last 100 ns of simulation and over 50 replicas of the peptide contained 
inside the simulation box. 
 
 
Figure 6. Structural analysis of p31-43 by Circular Dichroism shows PPII structure in 
equilibrium with β-sheet like structures. A) Spectra obtained at (●) 10µM (▼) 50µM, (■) 
100µM, (▲) 200µM and (●) 500µM peptide solution at 4ºC. B) Spectra of a 200µM solution 
at (●) 4ºC, (■) 10ºC, (▲) 25ºC and (▼) 37ºC. C) Spectra obtained at (●) 50µM and (■) 
200µM in 8M urea at 25°C. D) Spectra of a 200µM solution at difference concentrations of 
TFE: (■) 0%, (●) 10%, (▲) 20% and (▼) 30% and (●) 50% at 4°C. E) Difference spectra of 
37°C and 4°C spectra presented in figure B). F) Difference spectra of 0% and 50% TFE 
spectra presented in figure D). The spectrum obtained at each condition represents an 
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Figure 7: Time dependent morphological changes of p31-43 gliadin peptide at 10 
µM. AFM images were obtained in tapping mode (5 x 5μm2) by depositing the samples on 
the mica surface and drying by a nitrogen flux. The solutions were prepared in MilliQ water 
and incubated at 4°C at different time periods: A) freshly prepared sample (0 days) B) 4 
days and C) 7 days. Below each AFM image it is presented the cross section of the 
structures detected. In blue (a) the highest, in red (b) the middle and in green (c) the 
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Figure 8 Characterization of the structures observed by AFM of the 10 µM solution 
of p31-43. In A) it is presented in the size of the structures showed in figure 5 A (freshly 
prepared solution, n=100), B) correspond to figure 5 B (4 days incubated solution, n=25). 
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Figure 9: Time dependent morphological changes of p31-43 gliadin peptide at 50µM. 
AFM images were obtained in tapping mode by depositing the samples on mica surface 
and drying them by nitrogen flux. The solutions were prepared in MilliQ water and 
incubated at 4°C at different time periods: A) freshly prepared sample (0 days, 5 x 5μm2) 
B) Sample at day 4 (5 x 5μm2) and C) sample at day 7 (15 x 15μm2). Below each AFM 
image the cross section of the structures detected is presented. Color reference: blue (a) 
higher oligomers, red (b) intermediate oligomers and green (c) smaller oligomers. The 
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Figure 10. Height distribution of the 50 µM solution structures of p31-43 observed by 
AFM. In A) it is presented in the size of the structures showed in figure 6 A (freshly 
prepared solution, n=50), B) correspond to figure 6 B ( 4 days incubated solution, n=50)  
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Figure 11. Scheme of proposed self-organization process of p31-43. A) At 10μm it is 
observed that at initial times the peptide self-assembly on small spherical oligomers that 
progress to form planar clusters at 4 days. At 7 days structures progress to form higher 
oligomers. This process may occur by a Ostwald ripening. B) At 50μM p31-43 generate at 
initial stages spherical oligomers of different heights.  At 4 days interact forming linear 
arranges that progress to form fractal structures at 7 days. We propose that at this 
concentration the self-assembly process is govern by Diffusion Limited Aggregation (DLA)  
 
